3rd World ADC Asia 2024
Evvnt Promotion / evvnt
25.06.2024 - 27.06.2024 Grand Hyatt Incheon, 208 Yeongjonghaeannam-ro 321beon-gil, 22382 Jung-gu, Incheon, South Corea
Time: 8:00 am to 5:15 pm
Conference themes
The year 2024 has been considered the 'coming of age' era for antibody-drug conjugates, in great part due to the remarkable resurgence in drug development across the Asia-Pacific region. This part of the world is taking the ADC industry by storm with high-profile deals, multiple approvals, multiple ADCs moving into clinical trials, and novel targets being explored just to name some advancements.
The year 2024 has been considered the 'coming of age' era for antibody-drug conjugates, in great part due to the remarkable resurgence in drug development across the Asia-Pacific region. This part of the world is taking the ADC industry by storm with high-profile deals, multiple approvals, multiple ADCs moving into clinical trials, and novel targets being explored just to name some advancements.
Scientific Society
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/2191904-3?pid=4832
Speakers: Dohyun Nam, Chairman, Professor, Aimed Bio Inc., Jinwon Jung, Senior Directory, ABL Bio, Jia He, Senior Research Analyst Targeted Therapies, Beacon and More.
Brochure: https://go.evvnt.com/2191904-3?pid=4832
Speakers: Dohyun Nam, Chairman, Professor, Aimed Bio Inc., Jinwon Jung, Senior Directory, ABL Bio, Jia He, Senior Research Analyst Targeted Therapies, Beacon and More.
Enquiries and Registration:
https://go.evvnt.com/2191904-2?pid=4832
Ms. Jessica Durston
Oncology
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."